These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

650 related items for PubMed ID: 31077182

  • 21. Potential value of circulatory microRNA10b gene expression and its target E-cadherin as a prognostic and metastatic prediction marker for breast cancer.
    Dwedar FI, Shams-Eldin RS, Nayer Mohamed S, Mohammed AF, Gomaa SH.
    J Clin Lab Anal; 2021 Aug; 35(8):e23887. PubMed ID: 34264524
    [Abstract] [Full Text] [Related]

  • 22. Potential diagnostic role of circulating MiRNAs in breast cancer: Implications on clinicopathological characters.
    Swellam M, El Magdoub HM, Hassan NM, Hefny MM, Sobeih ME.
    Clin Biochem; 2018 Jun; 56():47-54. PubMed ID: 29679553
    [Abstract] [Full Text] [Related]

  • 23. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J, Raju GS, Chang DW, Lin SH, Chen Z, Wu X.
    Cancer; 2018 Feb 15; 124(4):785-796. PubMed ID: 29112225
    [Abstract] [Full Text] [Related]

  • 24. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.
    Erbes T, Hirschfeld M, Rücker G, Jaeger M, Boas J, Iborra S, Mayer S, Gitsch G, Stickeler E.
    BMC Cancer; 2015 Mar 28; 15():193. PubMed ID: 25886191
    [Abstract] [Full Text] [Related]

  • 25. Circulating microRNA-based screening tool for breast cancer.
    Frères P, Wenric S, Boukerroucha M, Fasquelle C, Thiry J, Bovy N, Struman I, Geurts P, Collignon J, Schroeder H, Kridelka F, Lifrange E, Jossa V, Bours V, Josse C, Jerusalem G.
    Oncotarget; 2016 Feb 02; 7(5):5416-28. PubMed ID: 26734993
    [Abstract] [Full Text] [Related]

  • 26. Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma.
    Heinemann FG, Tolkach Y, Deng M, Schmidt D, Perner S, Kristiansen G, Müller SC, Ellinger J.
    Clin Epigenetics; 2018 Feb 02; 10():11. PubMed ID: 29410711
    [Abstract] [Full Text] [Related]

  • 27. Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.
    Matamala N, Vargas MT, González-Cámpora R, Miñambres R, Arias JI, Menéndez P, Andrés-León E, Gómez-López G, Yanowsky K, Calvete-Candenas J, Inglada-Pérez L, Martínez-Delgado B, Benítez J.
    Clin Chem; 2015 Aug 02; 61(8):1098-106. PubMed ID: 26056355
    [Abstract] [Full Text] [Related]

  • 28. Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring.
    McGuire A, Brown JA, Kerin MJ.
    Cancer Metastasis Rev; 2015 Mar 02; 34(1):145-55. PubMed ID: 25721950
    [Abstract] [Full Text] [Related]

  • 29. Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis.
    Madhavan D, Peng C, Wallwiener M, Zucknick M, Nees J, Schott S, Rudolph A, Riethdorf S, Trumpp A, Pantel K, Sohn C, Chang-Claude J, Schneeweiss A, Burwinkel B.
    Carcinogenesis; 2016 May 02; 37(5):461-70. PubMed ID: 26785733
    [Abstract] [Full Text] [Related]

  • 30. MicroRNA expression as risk biomarker of breast cancer metastasis: a pilot retrospective case-cohort study.
    Marino AL, Evangelista AF, Vieira RA, Macedo T, Kerr LM, Abrahão-Machado LF, Longatto-Filho A, Silveira HC, Marques MM.
    BMC Cancer; 2014 Oct 02; 14():739. PubMed ID: 25277099
    [Abstract] [Full Text] [Related]

  • 31. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
    Krishnan P, Ghosh S, Wang B, Li D, Narasimhan A, Berendt R, Graham K, Mackey JR, Kovalchuk O, Damaraju S.
    BMC Genomics; 2015 Sep 29; 16():735. PubMed ID: 26416693
    [Abstract] [Full Text] [Related]

  • 32. Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.
    Motawi TM, Sadik NA, Shaker OG, El Masry MR, Mohareb F.
    Gene; 2016 Sep 30; 590(2):210-9. PubMed ID: 26827795
    [Abstract] [Full Text] [Related]

  • 33. Relative and Absolute Expression Analysis of MicroRNAs Associated with Luminal A Breast Cancer- A Comparison.
    Arabkari V, Clancy E, Dwyer RM, Kerin MJ, Kalinina O, Holian E, Newell J, Smith TJ.
    Pathol Oncol Res; 2020 Apr 30; 26(2):833-844. PubMed ID: 30840191
    [Abstract] [Full Text] [Related]

  • 34. Serum circulating microRNA profiling for identification of potential breast cancer biomarkers.
    Mar-Aguilar F, Mendoza-Ramírez JA, Malagón-Santiago I, Espino-Silva PK, Santuario-Facio SK, Ruiz-Flores P, Rodríguez-Padilla C, Reséndez-Pérez D.
    Dis Markers; 2013 Apr 30; 34(3):163-9. PubMed ID: 23334650
    [Abstract] [Full Text] [Related]

  • 35. Circulating miR-195 as a Therapeutic Biomarker in Turkish Breast Cancer Patients.
    Cecene G, Ak S, Eskiler GG, Demirdogen E, Erturk E, Gokgoz S, Polatkan V, Egeli U, Tunca B, Tezcan G, Topal U, Tolunay S, Tasdelen I.
    Asian Pac J Cancer Prev; 2016 Apr 30; 17(9):4241-4246. PubMed ID: 27797225
    [Abstract] [Full Text] [Related]

  • 36. Circulating microRNAs as specific biomarkers for breast cancer detection.
    Ng EK, Li R, Shin VY, Jin HC, Leung CP, Ma ES, Pang R, Chua D, Chu KM, Law WL, Law SY, Poon RT, Kwong A.
    PLoS One; 2013 Apr 30; 8(1):e53141. PubMed ID: 23301032
    [Abstract] [Full Text] [Related]

  • 37. Identification of circulating microRNA signatures for breast cancer detection.
    Chan M, Liaw CS, Ji SM, Tan HH, Wong CY, Thike AA, Tan PH, Ho GH, Lee AS.
    Clin Cancer Res; 2013 Aug 15; 19(16):4477-87. PubMed ID: 23797906
    [Abstract] [Full Text] [Related]

  • 38. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
    Nogales-Cadenas R, Cai Y, Lin JR, Zhang Q, Zhang W, Montagna C, Zhang ZD.
    Breast Cancer Res; 2016 Jul 22; 18(1):75. PubMed ID: 27449149
    [Abstract] [Full Text] [Related]

  • 39. Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers.
    van Schooneveld E, Wouters MC, Van der Auwera I, Peeters DJ, Wildiers H, Van Dam PA, Vergote I, Vermeulen PB, Dirix LY, Van Laere SJ.
    Breast Cancer Res; 2012 Feb 21; 14(1):R34. PubMed ID: 22353773
    [Abstract] [Full Text] [Related]

  • 40. Differentially expressed microRNAs in exosomes of patients with breast cancer revealed by next‑generation sequencing.
    Wu H, Wang Q, Zhong H, Li L, Zhang Q, Huang Q, Yu Z.
    Oncol Rep; 2020 Jan 21; 43(1):240-250. PubMed ID: 31746410
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.